Pharmagen, Inc. (OTC:PHRX)
Industry: Healthcare

Pharmagen, Inc. distributes specialty drugs to hospitals, acute care facilities, surgery centers, and other healthcare practitioners in the United States. The company sources and distributes specialty drugs, blood plasma derivatives, specialty products, vaccines, anti-infectives, and hard-to-find pharmaceuticals. It offers plasma derivatives for treating serious medical conditions, such as cancer, hemophilia, rheumatoid arthritis, multiple scleroses, blood disorders, hepatitis, and HIV; and specialty products for treating respiratory, oncology, cardiovascular, and hormonal syndromes. The company also manufactures and distributes health supplements, including Clotamin, a specialized over-the-counter multivitamin dietary supplement for patients on Warfarin. In addition, it sells traditional pharmaceuticals to its distribution customers, such as antibiotics, vaccines, and other oral and injectable pharmaceuticals; and specializes in the formulation of drugs. The company was formerly known as Sunpeaks Ventures, Inc. and changed its name to Pharmagen, Inc. in January 2013. Pharmagen, Inc. is based in Silver Spring, Maryland.

Current Quote*
Last: $0.001
Change: -0.000
Book: $Unk
Volume: 17,766

As Of: 05/29 13:02 ET
*Quotes delayed by 20min.

BuyIns.Net Alerts for Symbol PHRX

  • No BuyIns.Net Alerts Available for PHRX

Graphs for PHRX

3 Month Graph

6 Month Graph

1 Year Graph